Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study

          Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical StudyInitial patient enrollment anticipated during first quarter of 2025December 19, 2024 9:00 AM EST | Source: Envoy Medical, Inc.White Bear Lake, Minnesota--(Newsfile Corp. - December 19, 2024) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company, today announces it has selected seven study sites for participation in its pivotal clinical trial to investigate its fully implan ...